Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

Cost-effectiveness of extending HPV vaccination above age 26 years in the U.S.

Filetype[PDF-1.44 MB]


  • English

  • Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov